United States

Trius Therapeutics LLC (TSRX)

Track

Ticker: TSRX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Finn John Chief Scientific Officer Officer
Transaction date
Planned sale
Price
253.18
Quantity 16,088 +8.9%
Value US$1,693,695
MORNEAU MICHAEL VP Finance & CAO Officer
Transaction date
Planned sale
Price
130.49
Quantity 70,557 +21.5%
Value US$1,394,614
Finn John Chief Scientific Officer Officer
Transaction date
Planned sale
Price
130.48
Quantity 50,878 +37.5%
Value US$3,233,356
MORNEAU MICHAEL VP Finance & CAO Officer
Transaction date
Planned sale
Price
7.75
Quantity 20,000 -65.3%
Value US$155,000
POWELL MICHAEL Non-Executive Director
Transaction date
Planned sale
Price
5.64
Quantity 2,600 -2.2%
Value US$14,662
POWELL MICHAEL Non-Executive Director
Transaction date
Planned sale
Price
5.43
Quantity 16,100 -11.8%
Value US$87,426
TRUEX PAUL F Non-Executive Director
Transaction date
Purchase
Price
6.80
Quantity 2,000 +17.7%
Value US$13,600
THOMPSON JOHN CRAIG Chief Commercial Officer Officer
Transaction date
Purchase
Price
6.48
Quantity 133 +inf%
Value US$862
Finn John Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.00
Quantity 300 -0.2%
Value US$2,100
Finn John Chief Scientific Officer Officer
Transaction date
Planned sale
Price
6.00
Quantity 800 -0.5%
Value US$4,800
Schmid John P. CFO and Secretary Officer
Transaction date
Planned sale
Price
9.00
Quantity 400 -0.4%
Value US$3,600
Schmid John P. CFO and Secretary Officer
Transaction date
Planned sale
Price
8.00
Quantity 100 -0.1%
Value US$800
Schmid John P. CFO and Secretary Officer
Transaction date
Planned sale
Price
6.00
Quantity 200 -0.2%
Value US$1,200
Finn John Chief Scientific Officer Officer
Transaction date
Planned sale
Price
6.00
Quantity 500 -0.3%
Value US$3,000
TRUEX PAUL F Non-Executive Director
Transaction date
Purchase
Price
3.50
Quantity 1,000 +9.7%
Value US$3,500
POWELL MICHAEL Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 830,000 +29.8%
Value US$4,150,000
KPCB PBD Associates, LLC Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 4,901 +0.2%
Value US$24,505
KPCB PBD Associates, LLC Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 823,906 +52.7%
Value US$4,119,530
Versant Venture Capital III, L.P. Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 914,529 +39.4%
Value US$4,572,645
KPCB PBD Founders Fund, LLC Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 4,901 +53.0%
Value US$24,505
ATWOOD BRIAN G Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 914,529 +39.4%
Value US$4,572,645
InterWest Partners IX, LP General Partner Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 1,227,333 +52.9%
Value US$6,136,665
InterWest Partners IX, LP Venture Member Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 1,227,333 +52.9%
Value US$6,136,665
Prism Venture Partners V L P Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 1,194,035 +67.7%
Value US$5,970,175
SOFINNOVA VENTURE PARTNERS VII L P Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 830,000 +29.8%
Value US$4,150,000
Kjellson Nina S Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 1,227,333 +52.9%
Value US$6,136,665
KABAKOFF DAVID S Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 30,000 +656.5%
Value US$150,000
KPCB PANDEMIC & BIO DEFENSE FUND LLC Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 823,906 +53.0%
Value US$4,119,530
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-07-12 2013-07-12 PlS Planned sale Finn John

Chief Scientific Officer

Officer
16,088 +8.9%
253.18
US$1,693,695 		16,088 +8.9% 253.18 US$1,693,695
2013-07-12 2013-07-11 PlS Planned sale MORNEAU MICHAEL

VP Finance & CAO

Officer
70,557 +21.5%
130.49
US$1,394,614 		70,557 +21.5% 130.49 US$1,394,614
2013-07-12 2013-07-11 PlS Planned sale Finn John

Chief Scientific Officer

Officer
50,878 +37.5%
130.48
US$3,233,356 		50,878 +37.5% 130.48 US$3,233,356
2013-05-16 2013-05-14 PlS Planned sale MORNEAU MICHAEL

VP Finance & CAO

Officer
20,000 -65.3%
7.75
US$155,000 		20,000 -65.3% 7.75 US$155,000
2012-01-20 2012-01-19 PlS Planned sale POWELL MICHAEL Non-Executive Director
2,600 -2.2%
5.64
US$14,662 		2,600 -2.2% 5.64 US$14,662
2012-01-17 2012-01-17 PlS Planned sale POWELL MICHAEL Non-Executive Director
16,100 -11.8%
5.43
US$87,426 		16,100 -11.8% 5.43 US$87,426
2011-08-31 2011-08-29 B Purchase TRUEX PAUL F Non-Executive Director
2,000 +17.7%
6.80
US$13,600 		2,000 +17.7% 6.80 US$13,600
2011-08-24 2011-08-22 B Purchase THOMPSON JOHN CRAIG

Chief Commercial Officer

Officer
133 +inf%
6.48
US$862 		133 +inf% 6.48 US$862
2011-08-12 2011-08-12 PlS Planned sale Finn John

Chief Scientific Officer

Officer
300 -0.2%
7.00
US$2,100 		300 -0.2% 7.00 US$2,100
2011-08-10 2011-08-09 PlS Planned sale Finn John

Chief Scientific Officer

Officer
800 -0.5%
6.00
US$4,800 		800 -0.5% 6.00 US$4,800
2011-08-02 2011-08-01 PlS Planned sale Schmid John P.

CFO and Secretary

Officer
400 -0.4%
9.00
US$3,600 		400 -0.4% 9.00 US$3,600
2011-06-01 2011-06-01 PlS Planned sale Schmid John P.

CFO and Secretary

Officer
100 -0.1%
8.00
US$800 		100 -0.1% 8.00 US$800
2011-05-03 2011-05-03 PlS Planned sale Schmid John P.

CFO and Secretary

Officer
200 -0.2%
6.00
US$1,200 		200 -0.2% 6.00 US$1,200
2011-02-22 2011-02-18 PlS Planned sale Finn John

Chief Scientific Officer

Officer
500 -0.3%
6.00
US$3,000 		500 -0.3% 6.00 US$3,000
2010-11-24 2010-11-23 B Purchase TRUEX PAUL F Non-Executive Director
1,000 +9.7%
3.50
US$3,500 		1,000 +9.7% 3.50 US$3,500
2010-08-10 2010-08-06 B Purchase POWELL MICHAEL Non-Executive Director Large shareholder
830,000 +29.8%
5.00
US$4,150,000 		830,000 +29.8% 5.00 US$4,150,000
2010-08-10 2010-08-06 B Purchase KPCB PBD Associates, LLC Large shareholder
4,901 +0.2%
5.00
US$24,505 		4,901 +0.2% 5.00 US$24,505
2010-08-10 2010-08-06 B Purchase KPCB PBD Associates, LLC Large shareholder
823,906 +52.7%
5.00
US$4,119,530 		823,906 +52.7% 5.00 US$4,119,530
2010-08-10 2010-08-06 B Purchase Versant Venture Capital III, L.P. Large shareholder
914,529 +39.4%
5.00
US$4,572,645 		914,529 +39.4% 5.00 US$4,572,645
2010-08-10 2010-08-06 B Purchase KPCB PBD Founders Fund, LLC Large shareholder
4,901 +53.0%
5.00
US$24,505 		4,901 +53.0% 5.00 US$24,505
2010-08-10 2010-08-06 B Purchase ATWOOD BRIAN G Non-Executive Director Large shareholder
914,529 +39.4%
5.00
US$4,572,645 		914,529 +39.4% 5.00 US$4,572,645
2010-08-10 2010-08-06 B Purchase InterWest Partners IX, LP

General Partner

Large shareholder
1,227,333 +52.9%
5.00
US$6,136,665 		1,227,333 +52.9% 5.00 US$6,136,665
2010-08-10 2010-08-06 B Purchase InterWest Partners IX, LP

Venture Member

Large shareholder
1,227,333 +52.9%
5.00
US$6,136,665 		1,227,333 +52.9% 5.00 US$6,136,665
2010-08-10 2010-08-06 B Purchase Prism Venture Partners V L P Large shareholder
1,194,035 +67.7%
5.00
US$5,970,175 		1,194,035 +67.7% 5.00 US$5,970,175
2010-08-10 2010-08-06 B Purchase SOFINNOVA VENTURE PARTNERS VII L P Large shareholder
830,000 +29.8%
5.00
US$4,150,000 		830,000 +29.8% 5.00 US$4,150,000
2010-08-10 2010-08-06 B Purchase Kjellson Nina S Non-Executive Director Large shareholder
1,227,333 +52.9%
5.00
US$6,136,665 		1,227,333 +52.9% 5.00 US$6,136,665
2010-08-10 2010-08-06 B Purchase KABAKOFF DAVID S Non-Executive Director
30,000 +656.5%
5.00
US$150,000 		30,000 +656.5% 5.00 US$150,000
2010-08-10 2010-08-06 B Purchase KPCB PANDEMIC & BIO DEFENSE FUND LLC Large shareholder
823,906 +53.0%
5.00
US$4,119,530 		823,906 +53.0% 5.00 US$4,119,530
Explore more

More insider trading research around Trius Therapeutics LLC

More insider trades in United States
Insider trading in North America